a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease
Industry Biotechnology
A.I.dvisor indicates that over the last year, MREO has been loosely correlated with TERN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then TERN could also see price increases.
Ticker / NAME | Correlation To MREO | 1D Price Change % | ||
---|---|---|---|---|
MREO | 100% | -1.45% | ||
TERN - MREO | 36% Loosely correlated | -2.58% | ||
INZY - MREO | 34% Loosely correlated | -2.65% | ||
URGN - MREO | 33% Poorly correlated | +0.27% | ||
RNA - MREO | 31% Poorly correlated | -1.95% | ||
ACLX - MREO | 30% Poorly correlated | -1.67% | ||
More |